Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Esketamine at low dose
The First People's Hospital of Lianyungang
Insomnia
1 trial -
Esketamine nasal spray
United Therapeutics Europe Ltd
Depression
1 trial -
Esketamine, Sulfentanil or/and Remifentanil
Second Affiliated Hospital of Soochow University
Opioid Analgesic Adverse Reaction
1 trial -
Esketamine-lidocaine group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Chronic Pain
1 trial -
Esocheck/Esoguard
United Therapeutics Europe Ltd
Barrett Esophagus
1 trial -
Essential Amino Acid Enriched Whey Protein
United Therapeutics Europe Ltd
Whole-body Protein Balance
1 trial -
Estrogen
Ultragenyx UK Limited
Turner's Syndrome
1 trial -
Estrogen-bazedoxifene
United Therapeutics Europe Ltd
Hand Osteoarthritis
1 trial -
Etomidate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Complications
1 trial -
Evaluation of social, cultural and behavioral factors
International Peace Maternity and Child Health Hospital
Cardio-vascular Disease
1 trial -
Exclusive Enteral Nutrition Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn's Disease
1 trial -
Exforge HCT® or Three Individual drug amlodipine + valsartan + hydrochlorothiazide
The University of Hong Kong
Intracerebral Hemorrhage
1 trial -
ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules
Biotech Pharmaceutical Co.,
Cognitive Functions Perceptual Disturbances
1 trial -
Exparel block in arthroscopic shoulder surgery
Pacira Ireland Limited
Injury of Shoulder Region
1 trial -
Experimental
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Cognitive Health
1 trial -
Experimental group
The First People's Hospital of Lianyungang
Overweight or Obesity
1 trial -
External beam radiotherapy
International Peace Maternity and Child Health Hospital
Squamous Cell Carcinoma of the Head and Neck
1 trial -
FAST Technique
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ST-Segment Elevation Myocardial Infarction
1 trial -
FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Neoplasms
1 trial -
FSD-F2R6-A-CP
Quantum Biopharma
Acute Alcohol Intoxication
1 trial -
Facility HIVST
United Therapeutics Europe Ltd
HIV Infections
1 trial -
Favipiravir
The First People's Hospital of Lianyungang
COVID-19
1 trial -
Febuxostat
Takeda
Chronic Kidney Disease
1 trial -
Febuxostat
The First People's Hospital of Lianyungang
Refractory Gout
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources